Clorox Company (The) (CLX)

CLX Quantitative Snapshot

Academic risk and quality models computed from CLX's own filings and price history, not from analyst opinion.

Piotroski F-Score

3 / 9

Weak: only 3 of 9 fundamental-health tests pass, which is the range associated with deteriorating fundamentals.

Altman Z-Score

2.19

Altman Z in the 1.81 to 2.99 grey zone, the band where the model gives no clear bankruptcy verdict.

Beneish M-Score

-3.45

Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.

Sloan Accrual Ratio

-0.003

Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.

Forecast Volatility (30d)

30.9%

GARCH(1,1) 30-day annualised forecast, below the current 31.2% reading.

Market Beta (5-factor)

0.86

Fama-French 5-factor market beta. The five factors explain 23% of this stock's return variance; the rest is idiosyncratic.

Own 5-Year Median P/E

38.9

The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.

Model inputs as of 2026-10-13.